Design and rationale of the EMPA-VISION trial: investigating the metabolic effects of empagliflozin in patients with heart failure

Design and rationale of the EMPA-VISION trial: investigating the metabolic effects of empagliflozin in patients with heart failure

<br><strong>Aims<br></strong> Despite substantial improvements over the last three decades, heart failure (HF) remains associated with a poor prognosis. The sodium-glucose co-transporter-2 inhibitor empagliflozin demonstrated significant reductions of HF hospitalization in pa...

תיאור מלא

מידע ביבליוגרפי
Main Authors: Hundertmark, MJ, Agbaje, OF, Coleman, R, George, JT, Grempler, R, Holman, RR, Lamlum, H, Lee, J, Milton, JE, Niessen, HG, Rider, O, Rodgers, CT, Valkovič, L, Wicks, E, Mahmod, M, Neubauer, S
פורמט: Journal article
שפה:English
יצא לאור: Wiley Open Access 2021

פריטים דומים

פריטים דומים